Gottlieb On Gene Therapies: 'Very Seductive' To Think About Accelerated Approval Pathway
Accelerated approval would help agency monitor gene therapies for durability and off-target effects, US FDA commissioner says.
Accelerated approval would help agency monitor gene therapies for durability and off-target effects, US FDA commissioner says.